Are you passionate about medical writing and eager to make a difference in the world of biopharmaceuticals? We are looking for talented colleague to join our innovative and dedicated Medical Writing Team.

At Zealand Pharma, we are committed to advancing the development of peptide-based medicines to improve the lives of patients with unmet medical needs. Our Medical Writing Team plays a crucial role in this mission, working collaboratively to produce high-quality regulatory documents and scientific publications.

Currently, we are looking for a Principal Medical Writer with a strong background in medical science, excellent writing skills, and the ability to interpret and present complex scientific data clearly and accurately.

Responsibilities

• Preparation of regulatory documents and scientific manuscripts, including clinical summaries, regulatory meeting packages, investigator’s brochures, clinical study reports etc.
• Ensure all documents comply with regulatory requirements and company standards.
• Engage in cross-functional teams, including clinical research, regulatory affairs, and biostatistics, to reach project goals.
• Maintain up-to-date knowledge of therapeutic areas, regulatory guidelines, and industry best practices.
• Assist in the development and maintenance of document templates and writing standards.

Candidate profile

• Academic degree in a relevant scientific or medical discipline (e.g., Biology, Medicine, Pharmacy, Biochemistry, or related field).
• Several years of experience in medical writing, preferably in a pharmaceutical or biotechnology company.
• Strong knowledge of clinical research, regulatory processes, and scientific methodology.
• Excellent written and verbal communication skills.
• Ability to work independently and collaboratively in a team-oriented environment.
• Strong attention to detail and ability to produce high-quality work under tight deadlines.

Bonding to innovate ​

Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.​

Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.​

We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise. ​

We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.​

The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.​

Let’s bond and be bold ​

We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities.

To find out more about working at Zealand, visit https://www.zealandpharma.com/careers/zealand-as-a-workplace/

Interested? Please apply no later than August 9, 2024, or as soon as possible.

For further information, please contact Senior Director Anne Okkels Birk on abirk@zealandpharma.com. Due to vacation, please expect a delay in the response.


About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals, bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.